Confronting the practice of surgery on differentiated thyroid cancer with current guidelines in Germany: A multicenter trial;Chirurgische praxis und leitlinien beim differenzierten schilddrüsenkarzinom in Deutschland: Ein multizentrischer vergleich

NuklearMedizin

Volumn 44, Issue 5, 2005, Pages 185-191

  Schwab, Robert ^a   Wieler, H ^a   Birtel, S ^a   Ostwald Lenz, E ^a   Kaiser, K P ^a   Becker, H P ^a  

^a BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

Author keywords

Guidelines; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; CANCER SIZE; CANCER SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; FEMALE; GERMANY; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; NECK DISSECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; RECURRENT LARYNGEAL NERVE PALSY; RETROSPECTIVE STUDY; REVIEW; SURGICAL RISK; SURVIVAL RATE; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

EID: 27644484552     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625203     Document Type: Review

References (29)

1. Bal CS, Kumar A, Pant GS. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer. Nucl Med Commun 2003; 24: 203-8.
2. Baudin E, Travagli JP, Ropers J at al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 1998; 83: 553-9.
3. Bertz J, Hentschel S, Hundsdörfer G et al. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland (Hrsg). Krebs in Deutschland - Häufigkeit und Trends. 4. Ausgabe, Saarbrücken 2004: 80-2. (www.rki.de/KREBS)
4. Biermann M, Pixberg MK, Schuck A et al. Multicenter Study Differentiated Thyroid Carcinoma (MSDS). Diminished acceptance of adjuvant external beam radiotherapy. Nuklearmedizin 2003; 42: 244-50.
5. Chow SM, Law SCK, Chan JKC et al. Papillary microcarcinoma of the thyroid - prognostic significance of lymph node metastasis and multifocality. Cancer 2003; 98: 31-40.
6. Deutsche Krebsgesellschaft und Deutsche Gesellschaft für Chirurgie: Kurzgefasste interdisziplinäre Leitlinien: Maligne Schilddrü sentumoren. 3. Aufl. 2002. www.uni-duesseldorf.de/AWMF.
7. Dietlein, M, Dressler J, Eschner W et al. Verfahrensanweisung für die Iod-131-Ganzkörperszintigraphie beim differenzierten Schilddrüsenkarzinom (Version 2). Nuklearmedizin 2003; 42: 123-5.
8. Dietlein M, Dressler J, Grünwald F et al. Leitlinien zur Schilddrüsendiagnostik (Version 2). Nuklearmedizin 2003; 42: 109-15.
9. Dietlein M, Dressler J, Farahati J et al. Verfahrensanweisung zur Radioiodmerapie (RIT) beim differenzierten Schilddrüsenkarzinom (Version 2). Nuklearmedizin 2004; 43: 115-20
10. Dietlein M, Luyken WA, Schicha H et al. Incidental multifocal papillary microcarcinomas of the thyroid: Is subtotal thyroidectomy combined with radioiodine ablation enough ? Nucl Med Commun 2005; 26: 3-8.
11. Dietlein M, Schober O, Schicha H. Overtherapy or undertherapy for papillary thyroid microcarcinoma? Therapeutic considerations for radioiodine ablation. Nuklearmedizin 2004; 43: 107-14.
12. Dralle H, Grimm O. Lymphadenektomie beim Schilddrüsencarcinom. Chirurg 1996; 67: 788-806.
13. Eichhorn W, Tabler H, Lippold R et al. Prognostic factors determining long term survival in well differentiated thyroid cancer; an analysis of 484 patients undergoing therapy and aftercare at the same institution. Thyroid 2003; 13: 949-58.
14. Fürst H, Mühlig HP, Negele T. Therapie des papillären Mikrokarzinoms der Schilddrüse. Wie radikal soll behandelt werden? TZM News 2004; 1: 1-2.
15. Hay ID, Thompson GB, Grant CS et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002; 26: 879-85.
16. Goretzki PE, Lammers B. Therapie des okkulten Schilddrüsencarcinoms. In: Henning-Symposium Schilddrüse 2003. 16. Konferenz über die menschliche Schilddrüse. Heidelberg 2004. Berlin: de Gruyter 2004; 190-8
17. Hoelzer S, Steiner D, Bauer R et al. Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med 2000; 27: 1465-72.
18. Hoelzer S, Reiners C, Mann K et al. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer 2000; 89: 192-201.
19. Hundahl SA, Fleming ID, Fremgen AM et al. A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998; 83: 2638-48.
20. Ito Y, Tomoda C, Uruno T et al. Papillary microcarcinoma of the thyroid: How should it be treated? World J Surg 2004; 28: 886-9.
21. Mann K. Diagnostik und Therapie differenzierter Schilddrü senkarzinome. Internist 2002; 43: 174-85.
22. McHenry CR. Patient volumes and complications in thyroid surgery. Br J Surg 2002; 89: 821-3.
23. National Comprehensive Cancer Network (NCCN). Guidelines einsehbar im Internet unter: www.nccn.org/professionals/physician%20gls/ PDF/thyroid.pdf
24. Röher HD, Simon D, Witte J et al. Principles of limited or radical surgery for differentiated thyroid cancer. Thyroidology 1994; 5: 93.
25. Rosato L, Avenia N, Bernante P et al. Complications of thyroid surgery: analysis of a multicentric study on 14.934 patients operated on in Italy over 5 years. World J Surg 2004; 28: 271-6.
26. Rozeboom S, Schönberger J, Szikszai A et al. Initiale Befunde bei pT1-Schilddrüsenkarzinomen - Therapeutische Konsequenzen? Nuklearmedizin 2004; 43: A62-3.
27. Tan MP, Agarwal G, Reeve TS et al. Impact of timing on completion thyroidectomy for thyroid cancer. Br J Surg 2002; 89: 802-4.
28. Wieler H, Bartenstein P, Becker HP et al. Guideline for therapy of malignant thyroid tumors - Pleading for an actualization. Nuklearmedizin 2004; 43: 121-3.
29. Wittekind C, Meyer JH, Bootz F. TNM Klassifikation maligner Tumoren. 6. Aufl. Berlin: Springer 2003.